NON-BIOLOGICAL COMPLEX DRUGS CONCEPT IN GENERIC DRUGS DEVELOPMENT

NON-BIOLOGICAL COMPLEX DRUGS CONCEPT IN GENERIC DRUGS DEVELOPMENT

Expansion of the range of new medicines leads to a significant increase in healthcare spending and, consequently, to the appearance of more affordable generic drugs. A drug can be recognised as generic if there is sufficient evidence of equivalent structural characteristics of the active substance a...

Full description

Bibliographic Details
Main Authors:	D. V. Goryachev, Yu. V. Chernova, N. E. Uvarova
Format:	Article
Language:	Russian
Published:	NEICON ISP LLC 2018-03-01
Series:	Ведомости Научного центра экспертизы средств медицинского применения
Subjects:	generic drugs non-biological complex drugs glatiramoids iron-based nano-sized colloidal products liposome-encapsulated doxorubicin preclinical and clinical trials
Online Access:	https://www.vedomostincesmp.ru/jour/article/view/151

Similar Items

Practical Issues Concerning the Approval and Use of Biosimilar Drugs for the Treatment of Multiple Sclerosis in Latin America
by: Judith Steinberg, et al.
Published: (2019-05-01)

The concept of: Generic drugs and patented drugs Vs brand name drugs and non-proprietary (generic) name drugs.
by: Karan eThakkar, et al.
Published: (2013-09-01)

Evaluation of Bioequivalence of Generic Imatinib Products and Generic Tacrolimus Products Based on Indirect Comparison of the Results of Their Bioequivalence Studies
by: D. V. Goryachev, et al.
Published: (2019-09-01)

ORIGINAL OR GENERIC DRUG: THE PROBLEM OF CHOICE OF ANTIBIOTIC DRUGS IN RUSSIA
by: A. I. SINOPALNIKOV, et al.
Published: (2016-12-01)

Opinions of Czech general practitioners on generic drugs and substitution
by: Dosedel Martin, et al.
Published: (2014-12-01)

New prices for generic equivalent drugs
by: Ombretta Bandi
Published: (2011-11-01)

Bioequivalence trials for the approval of generic drugs in Saudi Arabia: a descriptive analysis of design aspects
by: Turki A. Althunian, et al.
Published: (2024-04-01)

Liposome: a carrier for effective drug delivery
by: Ananta Choudhury, et al.
Published: (2020-03-01)

Generic drugs: myths, facts, and limitations
by: Antonio Marzo, et al.
Published: (2012-10-01)

THE KARDIOKANON STUDY: A WAY TO SETTLE THE SUBJECT OF CLINICAL EQUIVALENCE OF GENERIC AND ORIGINAL DRUGS
by: S. Yu. Martsevich, et al.
Published: (2015-12-01)

WHAT IS THERAPEUTIC EQUIVALENCE OF GENERIC DRUG AND HOW TO PROVE IT
by: N. P. Kutishenko, et al.
Published: (2016-01-01)

Synthesis and physicochemical characterization of Arabic gum microgels modified with methacrylic acid as potential drug carriers
by: Ibrahim Sani M., et al.
Published: (2022-01-01)

Generic substitutions of antiepileptic drugs: Is it possible to put an end to the discussion?
by: E. A. Ushkalova, et al.
Published: (2018-07-01)

A multicenter randomized trials to compare the bioequivalence and safety of a generic doxorubicin hydrochloride liposome injection with Caelyx ® in advanced breast cancer
by: Yinjuan Li, et al.
Published: (2022-12-01)

Physicians’ generic drug prescribing behavior in district hospitals: a case of Phitsanulok, Thailand
by: Plianbangchang P, et al.
Published: (2010-09-01)

Nanomicelles: Types, properties and applications in drug delivery
by: Anamika Bose, et al.
Published: (2021-02-01)

COMPARISON OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC DRUGS OF SIMVASTATIN IN PATIENTS WITH HYPERLIPIDAEMIA AND HIGH RISK OF ISCHEMIC HEART DISEASE COMPLICATIONS
by: S. N. Tolpygina, et al.
Published: (2016-01-01)

The problem of choosing between the original and of generic drugs in patients with overweight and obesity
Published: (2013-10-01)

Analysis of patients’ request to switch from a generic drug to the original drug in external prescriptions
by: Yuhei Hamada, et al.
Published: (2020-12-01)

Risk Assessment of Failures in Generic Drug Development and Approval Procedure under Competitive Generic Drug Therapy and Patent Challenge Exclusivities Provided by the United States Food and Drug Administration
by: Reddy M Vivek, et al.
Published: (2022-03-01)

An empirical study of the impact of generic drug competition on drug market prices in China
by: Chen Yina, et al.
Published: (2023-05-01)

Lipodox® (generic doxorubicin hydrochloride liposome injection): in vivo efficacy and bioequivalence versus Caelyx® (doxorubicin hydrochloride liposome injection) in human mammary carcinoma (MX-1) xenograft and syngeneic fibrosarcoma (WEHI 164) mouse models
by: Vinod Burade, et al.
Published: (2017-06-01)

Promising Strategies of Colloidal Drug Delivery-Based Approaches in Psoriasis Management
by: Sukhbir Singh, et al.
Published: (2021-11-01)

STUDY OF CLINICAL EFFICACY OF ORIGINAL AND GENERIC DRUGS OF IVABRADINE IN PATIENTS WITH STABLE ANGINA (СOMPARATIVE STUDY)
by: S. V. Povetkin, et al.
Published: (2018-03-01)

Perception and attitude of Korean physicians towards generic drugs
by: Mikyung Ryu, et al.
Published: (2017-08-01)

Generic drug product development : solid oral dosage forms /
by: Shargel, Leon 1941-, editor, et al.
Published: (c201)

Perception of generic drugs among residents in a district of Peru
by: Ambrocio Teodoro Esteves Pairazaman, et al.
Published: (2023-11-01)

ACHIEVEMENT OF TARGET BLOOD PRESSURE LEVEL IN HYPERTENSIVE PATIENTS WITH AMLODIDINE: ORIGINAL DRUG VERSUS GENERIC
by: S. Yu. Martsevich, et al.
Published: (2016-01-01)

Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl®
by: Pietro Annovazzi, et al.
Published: (2018-11-01)

Scientific and regulatory approaches to confirm quality and improve patient perceptions of generic drug products in Japan
by: Hiroko Shibata, et al.
Published: (2016-10-01)

A comparison of generic drug prices in seven European countries: a methodological analysis
by: Olivier J. Wouters, et al.
Published: (2017-03-01)

The problem of choice: original drug or generic? Emphasis on rosuvastatin
by: O. A. Polyakova, et al.
Published: (2022-05-01)

Asymmetric Lipid Vesicles: Techniques, Applications, and Future Perspectives as an Innovative Drug Delivery System
by: Denisse Gardea-Gutiérrez, et al.
Published: (2023-05-01)

New Drugs - From Necessity to Delivery
by: Kedzierska Ewa, et al.
Published: (2018-06-01)

Transcriptome-wide elucidation of liposomal formulations for anticancer drug delivery
by: Huang, Bu-Wei, et al.
Published: (2018)

Correlation of reference and generic fluconazole-based drugs
by: A. S. Dukhanin
Published: (2020-04-01)

Antimicrobial drug-nutrition interactions: Consistency of information for generic drugs
by: Nikolić Božana
Published: (2020-01-01)

A survey and optical microscopy in pilot comparative analysis of generic and original nimesulide granules
by: Pavlo Leonenko, et al.
Published: (2021-07-01)

Representative sample survey on factors determining the Czech physicians’ awareness of generic drugs and substitution
by: J. Maly, et al.
Published: (2019-10-01)

The Temozolomide–Doxorubicin paradox in Glioblastoma in vitro–in silico preclinical drug-screening
by: Mariam-Eleni Oraiopoulou, et al.
Published: (2024-02-01)